Synta is deeply saddened by the recent passing of Dr. Judah Folkman on January 14, 2008.  Judah had been a member of our scientific advisory board since September 2003 and a member of our board of directors since September 2005.

Judah was a great scientist – prolific, productive, creative, original, and tenacious.  He was triumphantly correct on anti-angiogenesis.  But he did so much more: he developed the first implantable heart pacemaker and the first implantable drug-delivery capsule.  He was the youngest chief of surgery at Boston’s Children’s hospital as well as the youngest professor of surgery at Harvard.  He trained a legion of scientists who went out and made terrific contributions.  He helped so many patients and their families.

He was inspiring, he had the energy of twenty people, he was fun, and a great mentor and friend.  He is irreplaceable.  His passing is a tragedy for his family and a loss to science.

Judah was passionate about finding new ways to treat cancer, and we are proud and honored to continue his tradition at Synta.

Judah will be very much missed.

Safi Bahcall

President and CEO

Synta Pharmaceuticals Corp.